Enolase autoantibodies and retinal function in multiple sclerosis patients
- 12 January 2007
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 245 (8) , 1077-1084
Abstract
Background Electroretinographic (ERG) abnormalities have been reported in multiple sclerosis (MS), as well as the presence of circulating antiretinal antibodies. We and others have reported cases of impaired vision and diminished ERGs in MS patients with α-enolase autoantibodies. Anti-enolase antibodies have been implicated in autoimmune retinopathy. We performed this study to further explore the relationship between antiretinal antibodies and ERG changes in patients with MS. Methods Patients with clinically definite MS and normal visual acuity were recruited for this study, along with healthy controls. All patients and controls had ERG testing done according to ISCEV standards. Patient and control sera were analyzed for the presence of antiretinal antibodies using Western blot and ELISA techniques, and HLA class II typing was performed using polymerase chain reaction. Results We found a statistically significant difference between MS patients and controls in the rod-cone b-wave implicit time (p < 0.005). We found autoantibodies against α-enolase in 38% of MS patients and 11% of controls (p < 0.02). There was no statistically significant difference between ERG parameters of MS patients with α-enolase autoantibodies compared to those without α-enolase antibodies. Furthermore, the presence of α-enolase did not associate with a particular HLA haplotype. Conclusions Factors affecting the retina other than α-enolase antibodies may account for the delayed rod-cone b-wave implicit times observed in MS patients in this study. Anti-enolase antibodies are likely an epiphenomenon of autoimmune disease, and are not causing retinopathy in MS patients with normal visual acuity. However, the possibility of rare cases of patients with pathogenic α-enolase autoantibodies can not be excluded. The pathogenic contribution of these antibodies in MS patients with visual impairment deserves further investigation.Keywords
This publication has 60 references indexed in Scilit:
- The Decline of the Photopic Negative Response (PhNR) in the Rat after Optic Nerve TransectionDocumenta Ophthalmologica, 2005
- Cellular targets of anti-α-enolase autoantibodies of patients with autoimmune retinopathyJournal of Autoimmunity, 2004
- Retinal Antigens Are Recognized by Antibodies Present in Sera of Patients with Multiple SclerosisOphthalmic Research, 2004
- Biological indicators of the neurodegenerative phase of multiple sclerosisNeurological Sciences, 2003
- The role of T cells in autoimmune uveitisOcular Immunology and Inflammation, 2000
- The role of T cells in autoimmune uveitisOcular Immunology and Inflammation, 2000
- The Occurrence of Serum Autoantibodies against Enolase in Cancer-Associated RetinopathyClinical Immunology and Immunopathology, 1996
- Retinal Periphlebitis in Multiple Sclerosis: A Marker of Disease Activity?European Neurology, 1993
- Pattern Visual Evoked Potentials and Flash Electroretinogram in Clinically Definite Multiple SclerosisEuropean Neurology, 1985
- Neurophysiological investigation in optic nerve disease: combined assessment of the visual evoked response and electroretinogram.British Journal of Ophthalmology, 1978